(A) The schematic shows the experimental approach for NK cell depletion in the spontaneous C3-HET murine model. Twelve- to 15-week-old female mice with hyperplasia of mammary gland received anti-NK1.1 or isotype control immunoglobulin G (IgG) antibodies three times per week, and tumor growth was measured until humane end point for analysis. (B) Tumor burden per mouse (left; n = 8 mice per group), representative tumor images (middle), and calculated tumor volume (right), V = ½ (length × width2) upon NK cell depletion in C3-HET mice. (C) Hematoxylin and eosin–stained images of primary tumors upon NK cell depletion compared with IgG control group. (D) Cleaved caspase-3 staining (left) and quantification (right) of apoptotic cells in primary tumors upon NK cell depletion (n = 3 individual tumors per group, with analysis of n = 18 random fields from IgG tumors and n = 22 random fields from NK1.1-depleted tumors for quantification). (E) Immunostaining of cytotoxic CD8+ T cells in tumors from NK cell–depleted mice (arrowheads indicate positive staining; left) with quantification on the right (n = 3 individual tumors per group and n = 13 random fields per group). (F) Representative immunofluorescence (IF) images show expression of PD-L1+ primary tumor cells (red) upon NK cell depletion. Scatterplots (right) represent quantification (n = 3 individual tumors per group, n = 15 random fields from IgG tumors, and n = 12 random fields from NK1.1-depleted tumor for quantification). (G and H) Representative IF images (left) and quantification (right) show K14+ tumor cells (green) (G) and Vimentin+ cells (red) (H) in the axillary lymph node upon NK cell depletion (n = 5 individual lymph nodes). Two-tailed Student’s t test was used to compute P values. Data are presented as the mean ± SEM. Scale bars, 100 μm. DAPI, 4′,6-diamidino-2-phenylindole.